Purpose Ventures

808 Ventures is an investment management firm focused on early-stage technology investments. It describes itself as a venture capital firm and reports investments in Equal1 and StretchSense.

Right Click Capital is a venture capital manager backing technology startups, primarily at pre-seed and seed, with occasional later-round and follow-on investments.

Significant Ventures is an early-stage venture capital fund founded by the Hindmarsh family, investing in high-potential innovation from Australian universities and research institutions.

Constant Innovation is an early-stage venture capital firm based in Australia that invests in high-growth technology businesses.

SoHi Partners describes itself as a venture builder, advisor and fund manager; it reports investing in ventures and focuses on healthcare, agriculture and financial services.

Black Sheep Capital invests in early-stage technology companies, from concept/pre-seed through Series B, and provides founder support. Its stated investment scope also includes other assets.

Square Peg is a venture capital firm that invests in emerging technology companies across the internet economy in Australia and New Zealand, Southeast Asia, and Israel.

Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.

AirTree Ventures is an early and growth stage venture firm that invests in technology-enabled Australian and New Zealand companies. We invest at all stages of the startup lifecycle and love to write the first cheque for a promising young company. Airtree looks for world-class entrepreneurs who want to build iconic companies, and we do everything we can to assist in realising that vision. The AirTree team are entrepreneurs ourselves and have started companies whilst running big businesses across the globe. We understand what it takes to build a world-class company. The founders of our investee companies are everything to us. They are the foundation of what we do. We have rolled up our sleeves beside them and helped dozens of entrepreneurs achieve great outcomes over two decades. Our experience and hands on approach sets us apart from other investors. We are not just bobbing heads or cheerleaders. As a great founder you will always decide the path, you know your sector more intimately than we do. But we think it can be healthy to have a spirited, fact-based conversation first. In the past, we have had success investing in marketplaces, global SaaS businesses, next generation finance, digital commerce, and media and marketing platforms. Ultimately, we invest in disruptive businesses in any sector looking to reshape traditional industries and we support you to achieve your vision.

Titanium Ventures is an independent venture capital firm investing in high-potential technology startups, including companies using software and AI.

The CSIRO Innovation Fund (managed by and trading as Main Sequence Ventures) is a deeptech fund, investing in companies translating research into global-scale businesses. Main Sequence Ventures knows that this takes more than money. We have our genesis in CSIRO and have access to a deep well of data scientists, physicists, synthetic biologists, chemists, astronomers and experts in other disciples. Each member of the management team has been an entrepreneur and understands the difficulties of building a company. We are here to help. We work harder to understand the world that these founders imagine. We are as comfortable in the lab as we are on the front-line with customers. We will invest capital, and ourselves, to systematically reduce risk and increase opportunity by combining the operational velocity of startups with the deep curiosity of Australia's research sector.

OneVentures is an Australian investment manager with technology growth-equity and clinical-stage life-sciences investment pillars, alongside a growth-credit practice providing debt facilities to technology companies.